- Home
- BSBR vs A Comparison
BSBR vs A Comparison
Compare BSBR & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSBR
- A
- Stock Information
- Founded
- BSBR 1985
- A 1999
- Country
- BSBR Brazil
- A United States
- Employees
- BSBR N/A
- A N/A
- Industry
- BSBR Commercial Banks
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- BSBR Finance
- A Industrials
- Exchange
- BSBR Nasdaq
- A Nasdaq
- Market Cap
- BSBR 33.6B
- A 37.5B
- IPO Year
- BSBR 2009
- A 1999
- Fundamental
- Price
- BSBR $4.52
- A $133.83
- Analyst Decision
- BSBR
- A Buy
- Analyst Count
- BSBR 0
- A 17
- Target Price
- BSBR N/A
- A $143.07
- AVG Volume (30 Days)
- BSBR 473.6K
- A 2.0M
- Earning Date
- BSBR 10-29-2024
- A 11-25-2024
- Dividend Yield
- BSBR 6.78%
- A 0.71%
- EPS Growth
- BSBR 26.22
- A 25.91
- EPS
- BSBR 0.30
- A 4.81
- Revenue
- BSBR $8,670,618,732.00
- A $6,497,000,000.00
- Revenue This Year
- BSBR N/A
- A N/A
- Revenue Next Year
- BSBR N/A
- A $5.30
- P/E Ratio
- BSBR $7.43
- A $27.80
- Revenue Growth
- BSBR 8.02
- A N/A
- 52 Week Low
- BSBR $4.32
- A $123.48
- 52 Week High
- BSBR $6.66
- A $155.35
- Technical
- Relative Strength Index (RSI)
- BSBR 39.35
- A 49.97
- Support Level
- BSBR $4.32
- A $124.89
- Resistance Level
- BSBR $4.48
- A $143.07
- Average True Range (ATR)
- BSBR 0.08
- A 3.36
- MACD
- BSBR 0.00
- A 0.02
- Stochastic Oscillator
- BSBR 40.00
- A 49.17
About BSBR Banco Santander Brasil SA each representing one unit
Banco Santander (Brasil) SA is part of Santander Group, a Spanish bank. It operates across two segments; the Commercial Banking segment, catering to both individual and corporate client and the Global Wholesale Banking segment, which encompasses Investment Banking and Markets operations, including the Treasury and Equity Business Departments. The bank generates majority of its revenue from the Commercial Banking segment and has operations in Brazil and internationally.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.